CN1146772A - 用于治疗过敏反应的合成肽免疫原 - Google Patents

用于治疗过敏反应的合成肽免疫原 Download PDF

Info

Publication number
CN1146772A
CN1146772A CN95192778A CN95192778A CN1146772A CN 1146772 A CN1146772 A CN 1146772A CN 95192778 A CN95192778 A CN 95192778A CN 95192778 A CN95192778 A CN 95192778A CN 1146772 A CN1146772 A CN 1146772A
Authority
CN
China
Prior art keywords
gly
lys
phe
val
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95192778A
Other languages
English (en)
Chinese (zh)
Inventor
C·Y·王
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of CN1146772A publication Critical patent/CN1146772A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN95192778A 1994-03-28 1995-03-24 用于治疗过敏反应的合成肽免疫原 Pending CN1146772A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21846194A 1994-03-28 1994-03-28
US08/218,461 1994-03-28
US32891294A 1994-10-25 1994-10-25
US08/328,912 1994-10-25

Publications (1)

Publication Number Publication Date
CN1146772A true CN1146772A (zh) 1997-04-02

Family

ID=26912926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95192778A Pending CN1146772A (zh) 1994-03-28 1995-03-24 用于治疗过敏反应的合成肽免疫原

Country Status (6)

Country Link
EP (1) EP0811016A1 (enExample)
JP (1) JPH09510975A (enExample)
CN (1) CN1146772A (enExample)
AU (1) AU2195395A (enExample)
CA (1) CA2186595A1 (enExample)
WO (1) WO1995026365A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112237638A (zh) * 2020-10-28 2021-01-19 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
EP0885244B2 (en) 1996-03-01 2008-04-16 Novartis AG Peptide immunogens for vaccination against and treatment of allergy
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
AU3179999A (en) 1997-12-16 1999-07-05 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
WO2000065058A1 (en) 1999-04-23 2000-11-02 Pharmexa A/S Method for down-regulating il5 activity
GB9913327D0 (en) * 1999-06-08 1999-08-11 Smithkline Beecham Biolog Vaccine
US6846486B1 (en) 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
WO2001069253A2 (en) * 2000-03-15 2001-09-20 Heska Corporation 3d model of an fc epsilon receptor alpha chain-ige fc region complex
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
WO2002020038A2 (en) * 2000-09-06 2002-03-14 Pharmexa A/S Method for down-regulating ige
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2003047482A (ja) 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
WO2003015716A2 (en) 2001-08-13 2003-02-27 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
IL158287A0 (en) 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
US8697846B2 (en) * 2007-08-15 2014-04-15 Emory University Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology
WO2009113074A1 (en) * 2008-03-13 2009-09-17 Compugen Ltd. Novel gp96 derived peptides
EP2788021B1 (en) 2011-12-09 2017-01-18 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
US9187553B2 (en) * 2012-01-25 2015-11-17 Swey-Shen Chen Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
JP5918851B2 (ja) * 2012-06-18 2016-05-18 日本全薬工業株式会社 ＩｇＥペプチドワクチン
EP2790442A1 (en) 2013-04-09 2014-10-15 Alcatel Lucent Control system, apparatus, methods, and computer readable storage medium storing instructions for a network node and/or a network controller

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5552537A (en) * 1993-03-24 1996-09-03 The Regents Of The University Of California IgE isoforms and methods of use
AU687805B2 (en) * 1993-04-27 1998-03-05 United Biomedical Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112237638A (zh) * 2020-10-28 2021-01-19 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Also Published As

Publication number Publication date
AU2195395A (en) 1995-10-17
JPH09510975A (ja) 1997-11-04
WO1995026365A1 (en) 1995-10-05
EP0811016A1 (en) 1997-12-10
CA2186595A1 (en) 1995-10-05
EP0811016A4 (enExample) 1997-12-10

Similar Documents

Publication Publication Date Title
CN1259340C (zh) 作为免疫原治疗过敏症的肽组合物
CN1146772A (zh) 用于治疗过敏反应的合成肽免疫原
CN1201819C (zh) 人工t辅助细胞表位作为合成肽免疫原的免疫刺激物
CN1093881C (zh) 免疫原或诊断剂的制备及其获得免疫原或诊断试剂的方法
CN1174998C (zh) 用于预防和治疗过敏的肽免疫原
CN1207306C (zh) 用于预防和治疗hiv感染和免疫疾病的肽组合物
CN1282656C (zh) 来自gagp17和p24保守区域的HIV肽以及它们在例如疫苗中的应用
CN1688606A (zh) 含有辅助t细胞和b细胞表位的新的免疫原性脂肽
CN1568329A (zh) 一种用于预防和治疗阿尔兹海默氏病的具有免疫原性的肽组合物
CN1315869A (zh) 人工t辅助细胞表位作为包括免疫原性lhrh肽的合成肽免疫原的免疫刺激物
CN1679932A (zh) 抗原的有序分子呈递，制备及使用的方法
CN1913920A (zh) 流感免疫原和疫苗
CN1934127A (zh) Αβ免疫原性肽载体－偶联物及其生产方法
CN1688605A (zh) 包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽
CN1167491A (zh) 用于治疗变态反应的合成IgE膜锚肽免疫原
CN1354674A (zh) 用于口蹄疫的合成肽疫苗
CN101080239A (zh) 作为慢性肝炎治疗性疫苗的稳定化HBc嵌合体颗粒
CN1118474C (zh) 合成肽及包含其的疫苗
CN1483736A (zh) 用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
CN1838967A (zh) 稳定的免疫原性HBc嵌合体颗粒
CN87105411A (zh) B型肝炎病毒表面抗原前s区的t细胞和b细胞抗原决定基
CN1741818A (zh) 线虫多肽佐剂
CN1718243A (zh) 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用
CN1714153A (zh) 重组蛋白质变异体
CN1756562A (zh) 流感病毒疫苗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication